Portfolio company
Lanterna
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides fluorescent nucleobase analogues and tools for researchers to track and study RNA and nucleotides in real-time.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
RNAnalytics
This company develops modular analysis toolkits and software for lipid nanoparticle characterisation to support biotech and pharmaceutical firms developing RNA-based therapies.
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
LUMICKS
This company develops single-molecule and cell avidity analysis instruments for academic researchers and pharmaceutical companies to study biological mechanisms and develop life-saving therapies.
Etherna
This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.
Xterna
The company develops enhanced nucleic acids to provide targeted drug delivery solutions for pharmaceutical and biotechnology researchers seeking to treat previously inaccessible diseased tissues.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Inceptive Nucleics
This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.
Novarna
This company develops an artificial intelligence platform to design and validate RNA therapeutics for biopharmaceutical partners.
